{"pub": "washingtontimes", "url": "https://washingtontimes.com/news/2019/oct/8/johnson-johnson-risperdal-maker-hit-with-8b-verdic", "downloaded_at": "2019-10-09 00:46:27.867423+00:00", "title": "Johnson & Johnson, Risperdal maker hit with $8B verdict", "language": "en", "text": "PHILADELPHIA (AP) - A Philadelphia jury has decided that Johnson & Johnson and Janssen Pharmaceuticals should pay $8 billion over an antipsychotic drug that the plaintiff\u2019s attorneys say is linked to the growth of female breast tissue in boys.\n\nA law firm for the plaintiff released a statement Tuesday saying the companies used an organized scheme to make billions of dollars while illegally marketing and promoting the drug called Risperdal.\n\nJohnson & Johnson says the jury\u2019s award \u201cis grossly disproportionate with the initial compensatory award in this case,\u201d and that the company is \u201cconfident it will be overturned.\u201d\n\nSign up for Daily Newsletters Manage Newsletters\n\nCopyright \u00a9 2019 The Washington Times, LLC.", "description": "A Philadelphia jury has decided that Johnson & Johnson and Janssen Pharmaceuticals should pay $8 billion over an antipsychotic drug that the plaintiff's attorneys say is linked to the growth of female breast tissue in boys.", "authors": ["The Washington Times Http", "Associated Press"], "top_image": "https://twt-thumbs.washtimes.com/media/image/2019/10/08/johnson_johnson_risperdal_67899_c0-309-4650-3020_s1770x1032.jpg?1847708c4d046f0fd3c2346267a14019e4eca57f", "published_at": "2019-10-08"}